BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 11246234)

  • 1. SMART: The microstent's ability to limit restenosis trial.
    Heuser R; Lopez A; Kuntz R; Reduto L; Badger R; Coleman P; Whitlow P; Iannone LA; Safian R; Yeung A; Moses J;
    Catheter Cardiovasc Interv; 2001 Mar; 52(3):269-77; discussion 278. PubMed ID: 11246234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The PARAGON stent study: a randomized trial of a new martensitic nitinol stent versus the Palmaz-Schatz stent for treatment of complex native coronary arterial lesions.
    Holmes DR; Lansky A; Kuntz R; Bell MR; Buchbinder M; Fortuna R; O'Shaughnessy CD; Popma J
    Am J Cardiol; 2000 Nov; 86(10):1073-9. PubMed ID: 11074202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term angiographic and clinical outcome after implantation of balloon-expandable stents in aortocoronary saphenous vein grafts.
    Fenton SH; Fischman DL; Savage MP; Schatz RA; Leon MB; Baim DS; King SB; Heuser RR; Curry RC; Rake RC
    Am J Cardiol; 1994 Dec; 74(12):1187-91. PubMed ID: 7977087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Single-center experience with the Palmaz-Schatz intracoronary stent: the immediate results and medium- and long-term follow-up].
    Galassi AR; Tamburino C; Grassi R; Monaco A; Russo G; Ierna SM; Calvi V; Giuffrida G
    Cardiologia; 1996 Nov; 41(11):1097-105. PubMed ID: 9064207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coronary-artery stenting compared with balloon angioplasty for restenosis after initial balloon angioplasty. Restenosis Stent Study Group.
    Erbel R; Haude M; Höpp HW; Franzen D; Rupprecht HJ; Heublein B; Fischer K; de Jaegere P; Serruys P; Rutsch W; Probst P
    N Engl J Med; 1998 Dec; 339(23):1672-8. PubMed ID: 9834304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of immediate and follow-up results of the short and long NIR stent with the Palmaz-Schatz stent.
    Kobayashi Y; De Gregorio J; Kobayashi N; Reimers B; Albiero R; Vaghetti M; Finci L; Di Mario C; Colombo A
    Am J Cardiol; 1999 Sep; 84(5):499-504. PubMed ID: 10482144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3-year follow-up of the SISR (Sirolimus-Eluting Stents Versus Vascular Brachytherapy for In-Stent Restenosis) trial.
    Holmes DR; Teirstein PS; Satler L; Sketch MH; Popma JJ; Mauri L; Wang HP; Schleckser PA; Cohen SA;
    JACC Cardiovasc Interv; 2008 Aug; 1(4):439-48. PubMed ID: 19463342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stent placement compared with balloon angioplasty for obstructed coronary bypass grafts. Saphenous Vein De Novo Trial Investigators.
    Savage MP; Douglas JS; Fischman DL; Pepine CJ; King SB; Werner JA; Bailey SR; Overlie PA; Fenton SH; Brinker JA; Leon MB; Goldberg S
    N Engl J Med; 1997 Sep; 337(11):740-7. PubMed ID: 9287229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators.
    Fischman DL; Leon MB; Baim DS; Schatz RA; Savage MP; Penn I; Detre K; Veltri L; Ricci D; Nobuyoshi M
    N Engl J Med; 1994 Aug; 331(8):496-501. PubMed ID: 8041414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The stenotic stent: mechanisms and revascularization options.
    Topaz O; Vetrovec GW
    Cathet Cardiovasc Diagn; 1996 Mar; 37(3):293-9. PubMed ID: 8974810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimally deployed stents in the treatment of restenotic versus de novo lesions.
    Gruberg L; Hong MK; Mintz GS; Mehran R; Waksman R; Dangas G; Kent KM; Pichard AD; Satler LF; Lansky AJ; Kornowski R; Stone GW; Leon MB
    Am J Cardiol; 2000 Feb; 85(3):333-7. PubMed ID: 11078302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paclitaxel-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the TAXUS V ISR randomized trial.
    Stone GW; Ellis SG; O'Shaughnessy CD; Martin SL; Satler L; McGarry T; Turco MA; Kereiakes DJ; Kelley L; Popma JJ; Russell ME;
    JAMA; 2006 Mar; 295(11):1253-63. PubMed ID: 16531618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and angiographic outcome after Palmaz-Schatz stent implantation guided by intravascular ultrasound.
    Hall P; Nakamura S; Maiello L; Almagor Y; Gaglione A; Goldberg SL; Tobis JM; Martini G; Tucci G; Di Maggio M
    J Invasive Cardiol; 1995; 7 Suppl A():12A-22A. PubMed ID: 10155111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of heparin-coated stent in early setting of acute myocardial infarction.
    Shin EK; Son JW; Sohn MS; Jin DK; Park GS; Koh KK; Ahn TH; Choi IS
    Catheter Cardiovasc Interv; 2001 Mar; 52(3):306-12. PubMed ID: 11246241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized comparison of GR-II stent and Palmaz-Schatz stent for elective treatment of coronary stenoses.
    Lansky AJ; Roubin GS; O'Shaughnessy CD; Moore PB; Dean LS; Raizner AE; Safian RD; Zidar JP; Kerr JL; Popma JJ; Mehran R; Kuntz RE; Leon MB
    Circulation; 2000 Sep; 102(12):1364-8. PubMed ID: 10993853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and angiographic outcome of NIR stent implantation in small vessels with unfavorable lesion morphology.
    Miketic ; Carlsson J; Tebbe U
    J Invasive Cardiol; 1999 May; 11(5):269-73. PubMed ID: 10745529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Palmaz-Schatz stent implantation for aorto-ostial stenoses of native coronary arteries and saphenous vein grafts].
    Yamasaki M; Hara K; Masaki K; Kobayashi N; Nakajima H; Kouzuma K; Saeki F; Tamura T
    J Cardiol; 1998 May; 31(5):263-71. PubMed ID: 9617656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Are directional coronary atherectomy and Palmaz-Schatz stent more efficacious than conventional balloon angioplasty for treating de novo coronary artery lesions?].
    Nanasato M; Adachi M; Hirayama H; Tsuji Y; Yamada T; Yoshida Y; Yamada K; Miwata S; Tsuboi N; Itoh T; Maeda S; Kuriyama K
    J Cardiol; 1997 Sep; 30(3):117-24. PubMed ID: 9309507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary percutaneous coronary intervention by drug-eluting balloon angioplasty: the nonrandomized fourth arm of the DEB-AMI (drug-eluting balloon in ST-segment elevation myocardial infarction) trial.
    Nijhoff F; Agostoni P; Belkacemi A; Nathoe HM; Voskuil M; Samim M; Doevendans PA; Stella PR
    Catheter Cardiovasc Interv; 2015 Oct; 86 Suppl 1():S34-44. PubMed ID: 26119971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sirolimus- vs paclitaxel-eluting stents in de novo coronary artery lesions: the REALITY trial: a randomized controlled trial.
    Morice MC; Colombo A; Meier B; Serruys P; Tamburino C; Guagliumi G; Sousa E; Stoll HP;
    JAMA; 2006 Feb; 295(8):895-904. PubMed ID: 16493102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.